Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

Expert opinions on LDT transparency and standardization

Posted by Sam Blier on Oct 6, 2017 11:43:00 AM

Laboratory-developed tests (LDTs) have proliferated in the absence of clear guidelines and regulations. So how can laboratorians, physicians, and patients be assured of the quality of the diagnostic result? A panel of clinical genomics experts (Girish Putcha, MD, PhD, Director of Laboratory Science, Palmetto GBA; Roger Klein, MD, Principal, JD Consulting; Elaine Lyon, PhD, Medical Director, Molecular Genetics and Genomics, ARUP Laboratories; and Russell Garlick, PhD, CSO, SeraCare) delved into this topic during the audience Q&A session of a recent webinar hosted by GenomeWeb (you can download a full report on the entire series here).


Read More

Topics: LDT, clinical genomics, laboratory developed tests, guidelines and regulations, standardized approaches

ebook CTA image square Jan2019

Subscribe for Updates

Recent Posts


see all